About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
936
By Phase
PHASE3: 1EARLY_PHASE1: 1PHASE2: 1
By Status
RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05184335Lead Sponsor
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
PHASE3Recruiting
690 participants
Started: Jan 24, 2022 · Completed: Feb 28, 2025
NCT02932852Collaborator
Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases
EARLY_PHASE1Unknown
12 participants
Started: Nov 30, 2015
NCT01490086Lead Sponsor
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
PHASE2Completed
234 participants
Started: Dec 31, 2011 · Completed: Mar 31, 2013
Locations (1)
Headquarters
Cupertino, CA, United States
Map
Loading map...